About Mary Gunn
Form D filings for Med Aditus Pharmaceuticals in 2024 list Mary Gunn as director.
Mary Gunn first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mary Gunn in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mary Gunn works with at each company, as listed on that company's latest Form D.
Med Aditus Pharmaceuticals, Inc. · Form D, Nov 6, 2024
DS
David Stefanich
Director
KW
Kay Wagoner
Director
KR
Khama Rogo
Director
DT
Dhiren Thakker
President and CEO, director